Ninety-four projects representing 19 countries were funded at the Phase I level. Projects focused on identifying anti-malarial compounds, communicating the positive impact of development aid, protecting crop plants, new approaches to optimize immunizations, and new solutions for global health priority areas. In addition, 15 projects received Phase II awards of up to $1 million each to support promising Phase I work. Partners  Cannes Lions Medicines for Malaria Venture GlaxoSmithKline Tres Cantos Open Lab

Grand Challenges Explorations Round 9 Grants Awarded

GCE9_PhaseII.jpg

Grand Challenges Explorations

Announcements

Announcement

<p>Ninety-four projects representing 19 countries were funded at the Phase I level. Projects focused on identifying anti-malarial compounds, communicating the positive impact of development aid, protecting crop plants, new approaches to optimize immunizations, and new solutions for global health priority areas. In addition, 15 projects received Phase II awards of up to $1 million each to support promising Phase I work.</p>
<h2>Partners</h2>
<ul>
<li><a href="http://www.canneslions.com/" target="_blank" rel="noopener noreferrer">Cannes Lions</a></li>
<li><a href="http://www.mmv.org/malariabox" target="_blank" rel="noopener noreferrer">Medicines for Malaria Venture</a></li>
<li><a href="http://www.openlabfoundation.org/" target="_blank" rel="noopener noreferrer">GlaxoSmithKline Tres Cantos Open Lab</a></li>
</ul>
